Arthritis Research & Therapy

official impact factor 4.36

Open Access Highly Access

Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in rheumatoid arthritis by etanercept

Dirk Koczan, Susanne Drynda, Michael Hecker, Andreas Drynda, Reinhard Guthke, Joern Kekow and Hans-Juergen Thiesen*

Arthritis Research & Therapy 2008, 10:R50 doi:10.1186/ar2419

Accesses  

  • Last 30 days: 75 accesses
  • Last 365 days: 823 accesses
  • All time: 4853 accesses